The Neuroethics of Biomarkers: What the Development of Bioprediction Means for Moral Responsibility, Justice, and the Nature of Mental Disorder (Oxford Series in Neuroscience, Law, and Philosophy)

0 avg rating
( 0 ratings by Goodreads )
 
9780190236267: The Neuroethics of Biomarkers: What the Development of Bioprediction Means for Moral Responsibility, Justice, and the Nature of Mental Disorder (Oxford Series in Neuroscience, Law, and Philosophy)
View all copies of this ISBN edition:
 
 

Neuroscientists are mining nucleic acids, blood, saliva, and brain images in hopes of uncovering biomarkers that could help estimate risk of brain disorders like psychosis and dementia; though the science of bioprediction is young, its prospects are unearthing controversy about how bioprediction should enter hospitals, courtrooms, or state houses. While medicine, law, and policy have established protocols for how presence of disorders should change what we owe each other or who we blame, they have no stock answers for the probabilities that bioprediction offers. The Neuroethics of Biomarkers observes, however, that for many disorders, what we really care about is not their presence per se, but certain risks that they carry. The current reliance of moral and legal structures on a categorical concept of disorder (sick verses well), therefore, obscures difficult questions about what types and magnitudes of probabilities matter. Baum argues that progress in the neuroethics of biomarkers requires the rejection of the binary concept of disorder in favor of a probabilistic one based on biological variation with risk of harm, which Baum names a "Probability Dysfunction." This risk-reorientation clarifies practical ethical issues surrounding the definition of mental disorder in the DSM-5 and the nosology of conditions defined by risk of psychosis and dementia. Baum also challenges the principle that the acceptability of bioprediction should depend primarily on whether it is medically useful by arguing that biomarkers can also be morally useful through enabling moral agency, better assessment of legal responsibility, and fairer distributive justice. The Neuroethics of Biomarkers should be of interest to those within neuroethics, medical ethics, and the philosophy of psychiatry.

"synopsis" may belong to another edition of this title.

About the Author:


Matthew L. Baum, DPhil, is an MD-PhD trainee at Harvard & MIT within the Division of Health Sciences & Technology and the Harvard Program in Neuroscience. He earned a DPhil from Oxford via his work at the Oxford Centre for Neuroethics and the Ethox Center as a Rhodes Scholar. He holds an MSc in Neuroscience from Trinity College Dublin, where he studied as a Mitchell Scholar. He has also served as the student/post-doc representative to the board of the International Neuroethics Society.

Review:

"Our society is only beginning to come to grips with the profound implications of using biomarkers as imperfect 'crystal balls' for predicting the development of neurological and psychiatric disease. Dr. Baum's book is an essential guide to the scientific foundations of these tools and the
difficult ethical questions that they raise about moral responsibility and priority setting."

--Robert D. Truog, Frances Glessner Lee Professor of Medical Ethics, Anaesthesiology, and Pediatrics and Director of the Center for Bioethics, Harvard Medical School

"An exciting and comprehensive look at an important topic. Sure to be of interest to scientists and bioethicists working in the area."

--I. Glenn Cohen, Professor of Law and Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics, Harvard Law School

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 65.00
US$ 56.53

Convert currency

Shipping: FREE
From United Kingdom to U.S.A.

Destination, rates & speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

Matthew L. Baum
Published by Oxford University Press Inc, United States (2016)
ISBN 10: 0190236264 ISBN 13: 9780190236267
New Hardcover Quantity Available: 10
Seller:
Book Depository International
(London, United Kingdom)
Rating
[?]

Book Description Oxford University Press Inc, United States, 2016. Hardback. Condition: New. Language: English. Brand new Book. Neuroscientists are mining nucleic acids, blood, saliva, and brain images in hopes of uncovering biomarkers that could help estimate risk of brain disorders like psychosis and dementia; though the science of bioprediction is young, its prospects are unearthing controversy about how bioprediction should enter hospitals, courtrooms, or state houses. While medicine, law, and policy have established protocols for how presence of disorders should change what we owe eachother or who we blame, they have no stock answers for the probabilities that bioprediction offers. The Neuroethics of Biomarkers observes, however, that for many disorders, what we really care about is not their presence per se, but certain risks that they carry. The current reliance of moral andlegal structures on a categorical concept of disorder (sick verses well), therefore, obscures difficult questions about what types and magnitudes of probabilities matter. Baum argues that progress in the neuroethics of biomarkers requires the rejection of the binary concept of disorder in favor of a probabilistic one based on biological variation with risk of harm, which Baum names a "Probability Dysfunction. " This risk-reorientation clarifies practical ethical issues surrounding thedefinition of mental disorder in the DSM-5 and the nosology of conditions defined by risk of psychosis and dementia. Baum also challenges the principle that the acceptability of bioprediction should depend primarily on whether it is medically useful by arguing that biomarkers can also be morally usefulthrough enabling moral agency, better assessment of legal responsibility, and fairer distributive justice. The Neuroethics of Biomarkers should be of interest to those within neuroethics, medical ethics, and the philosophy of psychiatry. Seller Inventory # AOP9780190236267

More information about this seller | Contact this seller

Buy New
US$ 56.53
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

Matthew L. Baum
Published by Oxford University Press Inc, United States (2016)
ISBN 10: 0190236264 ISBN 13: 9780190236267
New Hardcover Quantity Available: 10
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Oxford University Press Inc, United States, 2016. Hardback. Condition: New. Language: English. Brand new Book. Neuroscientists are mining nucleic acids, blood, saliva, and brain images in hopes of uncovering biomarkers that could help estimate risk of brain disorders like psychosis and dementia; though the science of bioprediction is young, its prospects are unearthing controversy about how bioprediction should enter hospitals, courtrooms, or state houses. While medicine, law, and policy have established protocols for how presence of disorders should change what we owe eachother or who we blame, they have no stock answers for the probabilities that bioprediction offers. The Neuroethics of Biomarkers observes, however, that for many disorders, what we really care about is not their presence per se, but certain risks that they carry. The current reliance of moral andlegal structures on a categorical concept of disorder (sick verses well), therefore, obscures difficult questions about what types and magnitudes of probabilities matter. Baum argues that progress in the neuroethics of biomarkers requires the rejection of the binary concept of disorder in favor of a probabilistic one based on biological variation with risk of harm, which Baum names a "Probability Dysfunction. " This risk-reorientation clarifies practical ethical issues surrounding thedefinition of mental disorder in the DSM-5 and the nosology of conditions defined by risk of psychosis and dementia. Baum also challenges the principle that the acceptability of bioprediction should depend primarily on whether it is medically useful by arguing that biomarkers can also be morally usefulthrough enabling moral agency, better assessment of legal responsibility, and fairer distributive justice. The Neuroethics of Biomarkers should be of interest to those within neuroethics, medical ethics, and the philosophy of psychiatry. Seller Inventory # AOP9780190236267

More information about this seller | Contact this seller

Buy New
US$ 57.34
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

3.

Matthew L. Baum
Published by Oxford University Press
ISBN 10: 0190236264 ISBN 13: 9780190236267
New Quantity Available: > 20
Seller:
INDOO
(Avenel, NJ, U.S.A.)
Rating
[?]

Book Description Oxford University Press. Condition: New. Brand New. Seller Inventory # 0190236264

More information about this seller | Contact this seller

Buy New
US$ 55.72
Convert currency

Add to Basket

Shipping: US$ 3.60
Within U.S.A.
Destination, rates & speeds

4.

Matthew L. Baum (author)
Published by OUP USA 2016-04-07, New York, NY, United States of America (2016)
ISBN 10: 0190236264 ISBN 13: 9780190236267
New Hardcover Quantity Available: 5
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description OUP USA 2016-04-07, New York, NY, United States of America, 2016. hardback. Condition: New. Seller Inventory # 9780190236267

More information about this seller | Contact this seller

Buy New
US$ 54.83
Convert currency

Add to Basket

Shipping: US$ 9.74
From United Kingdom to U.S.A.
Destination, rates & speeds

5.

Baum, Matthew L.
Published by OUP USA (2016)
ISBN 10: 0190236264 ISBN 13: 9780190236267
New Quantity Available: 12
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description OUP USA, 2016. HRD. Condition: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Seller Inventory # FU-9780190236267

More information about this seller | Contact this seller

Buy New
US$ 53.37
Convert currency

Add to Basket

Shipping: US$ 11.69
From United Kingdom to U.S.A.
Destination, rates & speeds

6.

Matthew L. Baum
Published by Oxford University Press
ISBN 10: 0190236264 ISBN 13: 9780190236267
New Hardcover Quantity Available: 5
Seller:
THE SAINT BOOKSTORE
(Southport, United Kingdom)
Rating
[?]

Book Description Oxford University Press. Hardback. Condition: New. New copy - Usually dispatched within 2 working days. Seller Inventory # B9780190236267

More information about this seller | Contact this seller

Buy New
US$ 58.79
Convert currency

Add to Basket

Shipping: US$ 9.01
From United Kingdom to U.S.A.
Destination, rates & speeds

7.

THE NEUROETHICS OF BIOMARKERS WHAT THE DEVELOPMENT OF BIOPREDICTION MEANS FOR MORAL RESPONSIBILITY, JUSTICE, AND THE NATURE OF MENTAL DISORDER (HARDBACK) -
ISBN 10: 0190236264 ISBN 13: 9780190236267
New Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Condition: NEW. 9780190236267 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Seller Inventory # HTANDREE01579210

More information about this seller | Contact this seller

Buy New
US$ 65.54
Convert currency

Add to Basket

Shipping: US$ 10.39
From United Kingdom to U.S.A.
Destination, rates & speeds

8.

Matthew L. Baum
Published by Oxford University Press Inc, United States (2016)
ISBN 10: 0190236264 ISBN 13: 9780190236267
New Hardcover Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description Oxford University Press Inc, United States, 2016. Hardback. Condition: New. Language: English. Brand new Book. Neuroscientists are mining nucleic acids, blood, saliva, and brain images in hopes of uncovering biomarkers that could help estimate risk of brain disorders like psychosis and dementia; though the science of bioprediction is young, its prospects are unearthing controversy about how bioprediction should enter hospitals, courtrooms, or state houses. While medicine, law, and policy have established protocols for how presence of disorders should change what we owe eachother or who we blame, they have no stock answers for the probabilities that bioprediction offers. The Neuroethics of Biomarkers observes, however, that for many disorders, what we really care about is not their presence per se, but certain risks that they carry. The current reliance of moral andlegal structures on a categorical concept of disorder (sick verses well), therefore, obscures difficult questions about what types and magnitudes of probabilities matter. Baum argues that progress in the neuroethics of biomarkers requires the rejection of the binary concept of disorder in favor of a probabilistic one based on biological variation with risk of harm, which Baum names a "Probability Dysfunction. " This risk-reorientation clarifies practical ethical issues surrounding thedefinition of mental disorder in the DSM-5 and the nosology of conditions defined by risk of psychosis and dementia. Baum also challenges the principle that the acceptability of bioprediction should depend primarily on whether it is medically useful by arguing that biomarkers can also be morally usefulthrough enabling moral agency, better assessment of legal responsibility, and fairer distributive justice. The Neuroethics of Biomarkers should be of interest to those within neuroethics, medical ethics, and the philosophy of psychiatry. Seller Inventory # BZE9780190236267

More information about this seller | Contact this seller

Buy New
US$ 80.15
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

9.

Baum, Matthew L.
Published by Oxford Univ Pr (2016)
ISBN 10: 0190236264 ISBN 13: 9780190236267
New Hardcover Quantity Available: 1
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description Oxford Univ Pr, 2016. Hardcover. Condition: Brand New. 1st edition. 206 pages. 9.50x6.50x0.50 inches. In Stock. Seller Inventory # __0190236264

More information about this seller | Contact this seller

Buy New
US$ 70.69
Convert currency

Add to Basket

Shipping: US$ 9.74
From United Kingdom to U.S.A.
Destination, rates & speeds

10.

Matthew L. Baum
Published by OUP USA 2016-03-01 (2016)
ISBN 10: 0190236264 ISBN 13: 9780190236267
New Quantity Available: 5
Seller:
Chiron Media
(Wallingford, United Kingdom)
Rating
[?]

Book Description OUP USA 2016-03-01, 2016. Condition: New. Brand new book, sourced directly from publisher. Dispatch time is 3-4 working days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. Seller Inventory # NU-OUP-00102433

More information about this seller | Contact this seller

Buy New
US$ 56.28
Convert currency

Add to Basket

Shipping: US$ 38.85
From United Kingdom to U.S.A.
Destination, rates & speeds

There are more copies of this book

View all search results for this book